31801206|t|Transcriptomic Analysis of Stem Cells Treated with Moringin or Cannabidiol: Analogies and Differences in Inflammation Pathways.
31801206|a|Inflammation is a common feature of many neurodegenerative diseases. The treatment of stem cells as a therapeutic approach to repair damage in the central nervous system represents a valid alternative. In this study, using Next-Generation Sequencing (NGS) technology, we analyzed the transcriptomic profile of human Gingival Mesenchymal Stem Cells (hGMSCs) treated with Moringin [4-(alpha-l-ramanosyloxy)-benzyl isothiocyanate] (hGMSCs-MOR) or with Cannabidiol (hGMSCs-CBD) at dose of 0.5 or 5 microM, respectively. Moreover, we compared their transcriptomic profiles in order to evaluate analogies and differences in pro- and anti-inflammatory pathways. The hGMSCs-MOR selectively downregulate TNF-alpha signaling from the beginning, reducing the expression of TNF-alpha receptor while hGMSCs-CBD limit its activity after the process started. The treatment with CBD downregulates the pro-inflammatory pathway mediated by the IL-1 family, including its receptor while MOR is less efficient. Furthermore, both the treatments are efficient in the IL-6 signaling. In particular, CBD reduces the effect of the pro-inflammatory JAK/STAT pathway while MOR enhances the pro-survival PI3K/AKT/mTOR. In addition, both hGMSCs-MOR and hGMSCs-CBD improve the anti-inflammatory activity enhancing the TGF-beta pathway.
31801206	51	59	Moringin	Chemical	MESH:C000614007
31801206	63	74	Cannabidiol	Chemical	MESH:D002185
31801206	105	117	Inflammation	Disease	MESH:D007249
31801206	128	140	Inflammation	Disease	MESH:D007249
31801206	169	195	neurodegenerative diseases	Disease	MESH:D019636
31801206	438	443	human	Species	9606
31801206	498	506	Moringin	Chemical	MESH:C000614007
31801206	508	554	4-(alpha-l-ramanosyloxy)-benzyl isothiocyanate	Chemical	-
31801206	564	567	MOR	Gene	4988
31801206	577	588	Cannabidiol	Chemical	MESH:D002185
31801206	597	600	CBD	Chemical	MESH:D002185
31801206	760	772	inflammatory	Disease	MESH:D007249
31801206	794	797	MOR	Gene	4988
31801206	823	832	TNF-alpha	Gene	7124
31801206	922	925	CBD	Chemical	MESH:D002185
31801206	991	994	CBD	Chemical	MESH:D002185
31801206	1017	1029	inflammatory	Disease	MESH:D007249
31801206	1054	1058	IL-1	Gene	3552
31801206	1096	1099	MOR	Gene	4988
31801206	1173	1177	IL-6	Gene	3569
31801206	1204	1207	CBD	Chemical	MESH:D002185
31801206	1238	1250	inflammatory	Disease	MESH:D007249
31801206	1274	1277	MOR	Gene	4988
31801206	1309	1312	AKT	Gene	207
31801206	1313	1317	mTOR	Gene	2475
31801206	1344	1347	MOR	Gene	4988
31801206	1359	1362	CBD	Chemical	MESH:D002185
31801206	1380	1392	inflammatory	Disease	MESH:D007249
31801206	1416	1424	TGF-beta	Gene	7040
31801206	Association	MESH:D007249	7040
31801206	Negative_Correlation	MESH:D007249	4988
31801206	Association	MESH:D007249	3552
31801206	Negative_Correlation	MESH:D002185	3552
31801206	Positive_Correlation	MESH:D002185	7040
31801206	Negative_Correlation	MESH:D002185	MESH:D007249
31801206	Positive_Correlation	207	4988
31801206	Negative_Correlation	4988	7124
31801206	Positive_Correlation	4988	7040
31801206	Positive_Correlation	2475	4988

